当前位置: X-MOL 学术Eur. J. Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pulmonary hypertension across the spectrum of left heart and lung disease
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2024-06-04 , DOI: 10.1002/ejhf.3302
Barry A Borlaug 1 , Brett Larive 2 , Robert P Frantz 1 , Paul Hassoun 3 , Anna Hemnes 4 , Evelyn Horn 5 , Jane Leopold 6 , Franz Rischard 7 , Erika Berman-Rosenzweig 8 , Gerald Beck 2 , Serpil Erzurum 9 , Samar Farha 2 , J Emanuel Finet 10 , Kristin B Highland 2 , Miriam Jacob 10 , Christine Jellis 2 , Reena Mehra 9, 11 , Rahul Renapurkar 2 , Harsimran Singh 5 , W H Wilson Tang 9, 10 , Rebecca Vanderpool 12 , Jennifer Wilcox 11 , Shilin Yu 2 , Nicholas Hill 13
Affiliation  

Patients with pulmonary hypertension (PH) are grouped based upon clinical and haemodynamic characteristics. Groups 2 (G2, left heart disease [LHD]) and 3 (G3, lung disease or hypoxaemia) are most common. Many patients display overlapping characteristics of heart and lung disease (G2–3), but this group is not well-characterized.

中文翻译:


肺动脉高压涵盖左心和肺部疾病



肺动脉高压(PH)患者根据临床和血流动力学特征进行分组。第 2 组(G2,左心疾病 [LHD])和第 3 组(G3,肺部疾病或低氧血症)最常见。许多患者表现出心脏和肺部疾病的重叠特征(G2-3),但该组患者的特征并不明确。
更新日期:2024-06-04
down
wechat
bug